EGFR overexpression and its aberrant activity occur in over 90% of HNSCC cases and represent an independent prognostic marker correlating with increased tumor size, decreased radiation sensitivity, and increased risk of recurrence39. This evidence concerns the gene EGFR and neoplasm.